YYÜ GCRIS Basic veritabanının içerik oluşturulması ve kurulumu Research Ecosystems (https://www.researchecosystems.com) tarafından devam etmektedir. Bu süreçte gördüğünüz verilerde eksikler olabilir.
 

Acute Mesenteric Ischemia Due To Left Atrial Movable Thrombi in a Patient With Mitral Valve Replacement

dc.authorscopusid 55931157400
dc.authorscopusid 35520560800
dc.authorwosid Ekim, Hasan/Aam-3084-2021
dc.contributor.author Ekim, Hasan
dc.contributor.author Tuncer, Mustafa
dc.date.accessioned 2025-05-10T17:48:55Z
dc.date.available 2025-05-10T17:48:55Z
dc.date.issued 2008
dc.department T.C. Van Yüzüncü Yıl Üniversitesi en_US
dc.department-temp [Ekim, Hasan] Yuzuncu Yil Univ, Dept Cardiothorac Surg, Van, Turkey; [Tuncer, Mustafa] Yuzuncu Yil Univ, Dept Cardiol, Van, Turkey en_US
dc.description.abstract Background: Mesenteric ischemia associated with left atrial thrombosis is a serious complication that can occur after a mechanical mitral valve replacement. We performed an operation to remove the atrial thrombi leading to acute mesenteric ischemia. Possible cause of this thrombi formation is discussed. Case Report: A 47-year-old woman was transferred to our hospital for investigation of mesenteric ischemia thought to be cardiogenic in origin, 3 years after mitral valve replacement. She was initially admitted to Department of General Surgery after sudden abdominal pain and a diagnosis of mesenteric ischemia was made. The transesophageal echocardiogram showed a mechanical mitral valve and oscillating thrombi on the left atrium. The patient subsequently underwent an urgent open heart operation. The left atrial thrombi were removed without valve re-replacement. Histopathological study results of the operative specimen were consistent with thrombus. She had an uneventful postoperative recovery and was discharged from hospital 16 days after operation in good condition. Conclusions: We believe that the mesenteric thromboembolism was most likely caused by oscillating atrial thrombi due to inappropriate warfarin use and atrial fibrillation. Therefore, life-time follow-up and appropriate anticoagulant therapy is recommended to prevent thromboembolic events after the mechanical mitral valve replacement. en_US
dc.description.woscitationindex Emerging Sources Citation Index
dc.identifier.endpage 287 en_US
dc.identifier.issn 1941-5923
dc.identifier.scopus 2-s2.0-78249288497
dc.identifier.scopusquality Q2
dc.identifier.startpage 285 en_US
dc.identifier.uri https://hdl.handle.net/20.500.14720/17281
dc.identifier.volume 9 en_US
dc.identifier.wos WOS:000420352000075
dc.identifier.wosquality N/A
dc.language.iso en en_US
dc.publisher int Scientific Literature, inc en_US
dc.relation.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
dc.rights info:eu-repo/semantics/closedAccess en_US
dc.subject Mesenteric Ischemia en_US
dc.subject Left Atrial Thrombosis en_US
dc.subject Mechanical Mitral Valve en_US
dc.title Acute Mesenteric Ischemia Due To Left Atrial Movable Thrombi in a Patient With Mitral Valve Replacement en_US
dc.type Article en_US

Files